Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04965545

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
6 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up

Detailed description

Wilson disease is an autosomal recessive disorder that impairs copper homeostasis and is caused by homozygous or compound heterozygous mutations in ATP7B, which encodes a copper-transporting P-type ATPase. Patients have variable clinical manifestations and laboratory test results, resulting in diagnostic dilemmas. Therefore, the investigators aimed to identify factors associated with symptoms and features of Wilson disease, thereby give timely diagnosis for patients.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTlow copper dietAll patients with wilson disease should receive low copper diet

Timeline

Start date
2004-01-01
Primary completion
2025-12-01
Completion
2030-01-01
First posted
2021-07-16
Last updated
2021-07-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04965545. Inclusion in this directory is not an endorsement.

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease (NCT04965545) · Clinical Trials Directory